Neuroscientist Nadia Chaudhri Dies at 43

Knowingly facing the end of her life, she raised hundreds of thousands of dollars for underrepresented students in higher education.

Written byLisa Winter
| 2 min read
Nadia Chaudhri standing in front of a building, July 2021
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Nadia Chaudhri, a neuroscientist who studied drug and alcohol abuse, died on October 5 after a yearlong battle with ovarian cancer. She was 43. In the last year of her life, she became well known for the frank discussion of her declining health while also advocating for ovarian cancer research and fundraising to help underrepresented students further their education.

Chaudhri was born in Karachi, Pakistan. According to the website for The Nadia Chaudhri Wingspan Award, she came to the United States at the age of 17 to attend Franklin & Marshall College in Pennsylvania. After getting her undergraduate biology degree in 1999, she attended the University of Pittsburgh to get her PhD in neuroscience, which she completed in 2005. Then, she did a postdoc at the University of California, San Francisco.

She became an assistant professor at Concordia University in Montreal in 2010 and received tenure as an associate professor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies